Alzheimer-type dementia

Tohgi, H, Abe, T, Kimura, M, Saheki, M and Takahashi, S (1996) Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J. Neural Trans. 103 1211-1220. [Pg.394]

Cross AJ, Slater P, Perry EK, et al An autoradiographic analysis of serotonin receptors in human temporal cortex changes in Alzheimer-type dementia. Neurochem Int 13 89-96, 1988... [Pg.618]

Cross AJ, Crow TJ, Johnson JA, Dawson JM, Peters TJ (1985) Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntington s disease and Alzheimer-type dementia. J Neurol Sci 71 137-143. [Pg.333]

Asayama K, Yamadera H, Ito T, Suzuki H, Kudo Y, Endo S (2003) Double blind study of melatonin effects on the sleep-wake rhythm, Cognitive and non-cognitive functions in Alzheimer type dementia. J Nippon Med Sch 70 334-341... [Pg.206]

Arai H, Kosaka K, Iizuka R (1984) Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J. Neurochem. 43 388-393. [Pg.34]

Arai H, Ichimiya Y, Kosaka K, Moroji T, Iizuka R (1992) Neurotransmitter changes in early-and late-onset Alzheimer-type dementia. Prog. Neuropsychopharmacol. Biol. Psychiatry 16 883-890. [Pg.34]

Yates CM, Simpson J, Gordon A, Maloney AF, Allison Y, Ritchie IM, Urquhart A (1983) Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down s syndrome. Brain Res. 280 119-126. [Pg.43]

Brufani M, Marta M, Pomponi M. Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementia. Eur.J. Biochem., 986,... [Pg.21]

Physostigmine is an alkaloid, obtained from the seeds of the West African Calabar bean (spp. Physostigma), which has long been used both as a weapon and as an ordeal poison. It acts for a few hours. Physostigmine is used synergistically with pilocarpine to reduce intraocular pressure. It has been shown to have some efficacy in improving cognitive function in Alzheimer-type dementia. [Pg.437]

Campi N, Todeschini GP, Scarzella L (1990) Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia. Clin Ther 12 306-314... [Pg.148]

Prasher VP, Farrer MJ, Kessling AM, Fisher EMC, WestRJ, Barber SPC, Butler AC (1998) Molecular mapping of IIv Alzheimer-type dementia in Down s syndrome. Ann Neurol... [Pg.111]

K. Hager A. Marahrens M. Kenklies P. Riederer G. Munch, Alpha-lipoic acid as a new treatment option for Alzheimer type dementia. Arch. Geron. Geri. 2001, 32, 275-282. [Pg.208]

Certain inherited diseases are associated with abnormal trace metal metabolism, and this may be linked to MT synthesis, either directly or indirectly. Zinc, copper, and iron are the target elements in several diseases, and their concentrations may be altered in disorders of the central nervous system or other physiological systems, including Alzheimer-type dementia, amyotrophic lateral sclerosis, acrodermatitis enteropathica, biliary cirrhosis, Wilson s and Menke s diseases (Bremner 1987), epi-... [Pg.397]

Ichimiya. Y., Aral, H., Kosaka, K. and lizuka, R. (1986) Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia. Acta Neuropathol. 70 112-116. [Pg.491]

Iwamoto, N., Kobayashi, K. and Kosaka, K. (1989) The formation of prostaglandins in the post-mortem cerebral cortex of Alzheimer-type dementia patients. J. Neurol. 236 80-84. [Pg.492]

In patients with moderate Alzheimer-type dementia, chronic treatment with selegiline (10 mg daily) had some beneficial effects such as improvements in congnitive functions, learning, alertness and task performance . These observations are in line with results obtained in rats chronically treated with selegiline, in which active treatment significantly improved the learning capacity as compared to saline treated controls. ... [Pg.766]

Shimokawa, A., Yatomi, N., Anamizu, S., Torii, S., Isono, H., Sugai, Y., Kohno, M. Influence of deteriorating ability of emotional comprehension on interpersonal behaviour in Alzheimer-type dementia. Brain Cogn. 47, 423 33 (2001)... [Pg.281]

This is a new entity, sometimes diflUcult to differentiate from progressive primary aphasia or from probable Alzheimer-type dementia. It was individualised by Snowden et al. in 1989 [22]. Semantic dementia is a loss of performances which Tulving grouped under the term semantic memory [23]. The main clinical feature is the loss of the sense of words, things and persons. [Pg.11]

Rivastigmine (sold as its tartrate salt under the trade name Exelon Novartis, Basel, Switzerland) is an acetylcholinesterase inhibitor of the carbamate type whose (S)-enantiomer is prescribed for the treatment of mild-to-moderate Alzheimer-type dementia. Gotor-Fernandez, Gotor, and co-workers have reported on a DKR-based... [Pg.1687]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...